Array ( [0] => Applebot/0.1 [1] => facebookexternalhit/1.1 [2] => LinkedInBot/1.0 [3] => meta-externalagent/1.1 [4] => Amazonbot/0.1 [5] => BLEXBot/1.0 [6] => DotBot/1.2 [7] => Qwantbot/1.0_1997801 [8] => AhrefsBot/7.0 [9] => DataForSeoBot/1.0 [10] => MatchorySearch/1.3 [11] => WRTNBot/1.0 [12] => Sogou web spider/4.0 [13] => MojeekBot/0.11 [14] => Yeti/1.1 [15] => SeznamBot/4.0 [16] => SemrushBot-SI/0.97 [17] => MistralAI-User/1.0 [18] => Qwantbot/1.0 [19] => coccocbot-web/1.0 [20] => coccocbot-image/1.0 [21] => PlagAwareBot/3.2 [22] => Barkrowler/0.9 [23] => AwarioSmartBot/1.0 [24] => PetalBot [25] => archive.org_bot [26] => Iframely/1.3.1 [27] => LogRocket-AssetCacher [28] => Slackbot 1.0 [29] => node-fetch/1.0 [30] => MJ12bot/v1.4.8 [31] => MJ12bot/v2.0.0 [32] => Timpibot/0.9 [33] => AwarioBot/1.0 [34] => MJ12bot/v2.0.1 [35] => Qwantbot/1.0_2850318 [36] => SiteAuditBot/0.97 [37] => Scrapy/2.11.2 [38] => CCBot/2.0 [39] => MJ12bot/v2.0.2 [40] => Scrapy/2.13.3 [41] => WordPress/6.8.3 [42] => MJ12bot/v2.0.4 [43] => SemrushBot/7~bl [44] => Qwairy-Bot/1.0 [45] => Embedly/0.2 [46] => GeedoProductSearch [47] => SemrushBot [48] => vkShare [49] => inkrich [50] => Discordbot/2.0 [51] => IbouBot/1.0 [52] => trafilatura/1.6.3 [53] => AnsehnBot/1.0 [54] => WP-URLDetails/6.8.3 [55] => HubSpot Crawler [56] => ShapBot/0.1.0 [57] => udu/1.6.5 [58] => aiohttp/3.13.1 [59] => l9scan/2.0 [60] => Trident/5.0 [61] => SmartBotCrawler/1.0 [62] => ) The user agent is not in the allowed list.Array ( [0] => pingbot/2.0 [1] => Googlebot/2.1 [2] => ChatGPT-User/1.0 [3] => PerplexityBot/1.0 [4] => OAI-SearchBot/1.0 [5] => GPTBot/1.2 [6] => Perplexity-User/1.0 [7] => YandexBot/3.0 [8] => YandexFavicons/1.0 [9] => AdsBot-Google-Mobile [10] => AdsBot-Google [11] => Gemini-Deep-Research [12] => DuckAssistBot/1.1 [13] => DuckDuckBot/1.1 [14] => GoogleOther [15] => YandexRenderResourcesBot/1.0 [16] => YandexImages/3.0 [17] => DuckAssistBot/1.2 [18] => Baiduspider/2.0 [19] => Baiduspider-render/2.0 [20] => bingbot/2.0 [21] => YandexUserproxy [22] => Pingdom.com_bot_version_1.4_ [23] => GPTBot/1.3 [24] => PingdomPageSpeed/1.0 [25] => YandexMobileBot/3.0 [26] => OAI-SearchBot/1.3 [27] => ClaudeBot/1.0 [28] => OAI-SearchBot/1.3 [29] => ) The user agent is an allowed/known agent.
Phototherapy Equipment Market Size & Growth Forecast 2026–2035, By Segments (End-use, Application, Product), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Base Year Value (2025)
USD 426.07 Million
CAGR (2026-2035)
4.2%
Forecast Year Value (2035)
USD 642.92 Million
Historical Data Period
2022-2025
Largest Region
North America
Forecast Period
2026-2035
Phototherapy Equipment Market Intelligence Snapshot:
-
Regional Market Dynamics:
- North America held a 41.34% market share in 2025, driven by established hospital and neonatal care infrastructure, routine equipment replacement, specialized care access, and strong integration of phototherapy systems into clinical workflows.
- Asia Pacific is expected to expand at a 4.79% CAGR as healthcare capacity grows, maternal and neonatal services expand, and hospitals increase adoption of phototherapy equipment to serve rising patient volumes.
-
Segment Momentum:
- Hospitals & Clinics accounted for 78.66% of the market in 2025, supported by trained staff, continuous patient monitoring, physician supervision, and access to a broad range of phototherapy equipment.
- Neonatal Jaundice Management is the fastest-growing application because phototherapy remains a frontline treatment for newborn care, creating consistent demand for timely and effective bilirubin management.
-
Market Expansion Drivers:
- Rising prevalence of neonatal jaundice increasing adoption of hospital and home-based phototherapy systems.
- Growing incidence of psoriasis and eczema expanding dermatological phototherapy treatment demand.
- Increasing deployment of portable LED-based phototherapy devices improving rural healthcare accessibility.
-
Leading Market Participants:
Key companies in the phototherapy equipment market include Koninklijke Philips N.V. (Netherlands), GE HealthCare Technologies Inc. (United States), Natus Medical Incorporated (United States), Herbert Waldmann GmbH & Co. KG (Germany), Atom Medical Corporation (Japan), Nice Neotech Medical Systems Pvt. Ltd. (India), Phoenix Medical Systems Pvt. Ltd. (India), National Biological Corporation (United States), Solarc Systems Inc. (Canada), Drägerwerk AG & Co. KGaA (Germany).
Global Market Forecast Snapshot:
-
Market Outlook:
- 2025 Market Size: USD 426.07 Million
- 2026 Market Size: USD 15.2 billion
- Projected Market Size: USD 642.92 Million by 2035
- Growth Forecasts: 4.2% CAGR (2026-2035)
-
Regional and Segment Outlook:
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Hospitals & Clinics (End-use) | Skin Disease Treatment (Application) | LED Phototherapy Equipment (Product)
- Emerging Opportunity Segment: Homecare (End-use) | Neonatal Jaundice Management (Application) | LED Phototherapy Equipment (Product)
Market Growth Drivers and Industry Trends
Rising prevalence of neonatal jaundice increasing adoption of hospital and home-based phototherapy systemsAs neonatal jaundice remains a routine clinical concern immediately after birth, care providers are expanding access to treatment pathways that can be deployed quickly and safely, driving demand for the phototherapy equipment market. Hospitals continue investing in intensive phototherapy units for maternity wards and neonatal care settings because timely bilirubin reduction is closely tied to care quality, discharge management, and avoidance of escalation into more complex interventions. At the same time, rising comfort with monitored home-based treatment is influencing market adoption of compact phototherapy systems that support earlier discharge and reduce pressure on inpatient capacity, creating a broader product mix shaped by both acute care protocols and post-discharge neonatal management.
Growing incidence of psoriasis and eczema expanding dermatological phototherapy treatment demand
A larger patient pool with chronic inflammatory skin conditions is supporting market development in the phototherapy equipment market by increasing the use of non-systemic treatment options in dermatology practice. For psoriasis and eczema, phototherapy often occupies an important position between topical management and more costly or intensive therapies, which leads clinics to maintain or expand installed equipment as treatment volumes rise. This also influences market penetration through repeat-treatment care models, since these conditions commonly require scheduled sessions over time, supporting ongoing utilization of phototherapy cabins, targeted devices, and clinic-based treatment capacity.
Increasing deployment of portable LED-based phototherapy devices improving rural healthcare accessibility
The shift toward portable LED systems is contributing to market size growth in the phototherapy equipment market by making treatment more feasible in settings that cannot support large, infrastructure-heavy equipment. Rural hospitals, primary care centers, and outreach health programs are more likely to adopt devices that are easier to transport, install, and operate, especially where specialist care and continuous facility resources are limited. LED-based designs also fit practical procurement priorities by reducing maintenance burden and improving usability, which supports wider equipment placement and increases treatment availability in underserved areas where conventional phototherapy access has historically been constrained.
| Growth Driver Assessment Framework | |||||
| Growth Driver | Impact On CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of neonatal jaundice increasing adoption of hospital and home-based phototherapy systems | 2.00% | Moderate | North America, Asia Pacific | High | Near Term |
| Growing incidence of psoriasis and eczema expanding dermatological phototherapy treatment demand | 1.70% | Moderate | North America, Europe | High | Mid Term |
| Increasing deployment of portable LED-based phototherapy devices improving rural healthcare accessibility | 1.30% | Moderate | Asia Pacific, Latin America, Middle East & Africa | Emerging | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions - Click to get your customized report now!
Regional Demand Dynamics
Largest Region
North America
41.34% Market Share in 2025
North America held the leading position in 2025, accounting for a 41.34% share of the phototherapy equipment market. This leadership is supported by the region’s well-established hospital and neonatal care infrastructure, where phototherapy systems are routinely used in the treatment of neonatal jaundice and dermatological conditions. Consistent equipment replacement cycles, broader access to specialized care settings, and stronger integration of advanced treatment devices into clinical workflows help maintain high purchasing activity across healthcare providers.
Asia Pacific is projected to expand at a 4.79% CAGR over the forecast period, with growth in the phototherapy equipment market being impelled by the steady expansion of healthcare capacity and rising access to maternal, neonatal, and dermatology services. Demand is accelerating as hospitals and clinics add essential treatment equipment to serve larger patient volumes, particularly in developing healthcare systems where facility upgrades and wider treatment availability are increasing adoption in day-to-day care delivery.
| Regional Market Attractiveness & Strategic Fit Matrix | |||||
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub | Advanced | Developing | Advanced | Developing | Nascent |
| Cost-Sensitive Region | Medium | High | Medium | High | High |
| Regulatory Environment | Supportive | Neutral | Restrictive | Neutral | Neutral |
| Demand Drivers | Moderate | Moderate | Moderate | Weak | Weak |
| Development Stage | Developed | Developing | Developed | Emerging | Emerging |
| Adoption Rate | Medium | Medium | Medium | Low | Low |
| New Entrants / Startups | Moderate | Sparse | Moderate | Sparse | Sparse |
| Macro Indicators | Strong | Stable | Strong | Weak | Weak |
Key Country Insights
The U.S. is increasing adoption of phototherapy equipment across dermatology and neonatal care, with growing interest in portable systems for home-based treatment. Manufacturers are developing user-friendly devices that improve treatment accessibility while maintaining clinical effectiveness.
Japan is expanding phototherapy equipment use to address rising dermatological care needs alongside established neonatal treatment programs. Healthcare facilities are adopting compact and energy-efficient systems that improve patient comfort and treatment consistency.
South Korea is incorporating advanced phototherapy equipment into dermatology clinics and hospitals through continued investment in medical technology. Demand is centered on versatile systems that support both aesthetic and therapeutic treatment applications.
Germany is emphasizing phototherapy equipment with precise light delivery and standardized treatment protocols for dermatological and neonatal applications. Healthcare providers are upgrading equipment that supports reliable therapeutic performance and efficient clinical workflows.
France is strengthening phototherapy equipment adoption through updated treatment protocols in dermatology and neonatal care. Healthcare providers are investing in reliable systems that improve treatment precision while supporting efficient patient management.
Italy is modernizing phototherapy equipment across hospitals and specialty clinics to improve treatment quality for skin disorders and neonatal jaundice. Clinical investments prioritize dependable technologies that enhance operational efficiency and patient outcomes.
Segment Leadership and Growth Trends
Hospitals & Clinics held the dominant position in the phototherapy equipment market in 2025, accounting for a 78.66% share. This dominance is sustained by the concentration of phototherapy procedures in clinical settings where trained staff, continuous patient monitoring, and access to a wider range of equipment support routine treatment delivery. In the phototherapy equipment market, hospitals and clinics also remain the primary point of care for patients requiring structured treatment protocols, particularly where physician supervision and repeat sessions are important to treatment outcomes.
Homecare is emerging as the fastest-growing end-use segment in the phototherapy equipment market as treatment demand increasingly aligns with convenience, longer-term condition management, and reduced dependence on facility-based care. Its momentum is reinforced through the practical shift toward therapies that patients can use outside hospitals and clinics, especially when repeated sessions are needed over time. Compared with conventional institutional settings, homecare gains traction because it fits more easily into ongoing treatment routines while helping ease access constraints tied to appointment-based care.
Application Segment Analysis: Skin Disease Treatment (Largest Segment) vs Neonatal Jaundice Management (Fastest-Growing Segment)
In 2025, Skin Disease Treatment represented the largest application in the phototherapy equipment market, with a 65.38% share. Its leadership reflects the established use of phototherapy across dermatology care, where treatment is routinely applied for chronic and recurring skin conditions that often require multiple supervised sessions. Within the phototherapy equipment market, this application benefits from consistent clinical adoption and a broad treatment base that keeps demand anchored in standard care pathways.
Neonatal Jaundice Management is the fastest-growing application in the phototherapy equipment market, influenced by the essential role of phototherapy as a frontline intervention in newborn care. Growth is being reinforced through the practical need for timely treatment in neonatal settings, where phototherapy equipment is used to manage bilirubin levels quickly and efficiently. Relative to other applications, this segment is gaining momentum because its use is closely tied to immediate clinical need, making equipment adoption more directly linked to routine neonatal care delivery.
| Report Segmentation | |||
| Segment | Sub-Segment | Largest Segment | Fastest Growing Segment |
|---|---|---|---|
| End-use | Hospitals & Clinics, Homecare | Hospitals & Clinics | Homecare |
| Application | Skin Disease Treatment, Neonatal Jaundice Management | Skin Disease Treatment | Neonatal Jaundice Management |
| Product | Conventional Phototherapy Equipment, LED Phototherapy Equipment, Fiber Optic Phototherapy Equipment | LED Phototherapy Equipment | LED Phototherapy Equipment |
Read our Research ApproachCompetitive Landscape and Market Positioning
Company Profile
Business Overview Financial Highlights Product Landscape SWOT Analysis Recent Developments Company Heat Map Analysis
1. Koninklijke Philips N.V. (Netherlands)
2. GE HealthCare Technologies Inc. (United States)
3. Natus Medical Incorporated (United States)
4. Herbert Waldmann GmbH & Co. KG (Germany)
5. Atom Medical Corporation (Japan)
6. Nice Neotech Medical Systems Pvt. Ltd. (India)
7. Phoenix Medical Systems Pvt. Ltd. (India)
8. National Biological Corporation (United States)
9. Solarc Systems Inc. (Canada)
10. Drägerwerk AG & Co. KGaA (Germany)
The phototherapy equipment market is witnessing strong innovation driven by increasing adoption of advanced light-based treatment systems across healthcare settings. Manufacturers are developing energy-efficient devices with improved wavelength precision, portability, and treatment customization features. Expansion of neonatal care infrastructure and growing awareness regarding non-invasive therapeutic options are also supporting broader market penetration.
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Enugu State University Teaching Hospital | May-26 | The Enugu State Government renovated and re-equipped the Neonatal and Special Babies Ward at Enugu State University Teaching Hospital. This infrastructure upgrade enhances the facility's capacity for neonatal care, including the provision of specialized phototherapy equipment required for treating hyperbilirubinemia in newborns. |
| Mennen Medical | May-25 | Mennen Medical received FDA clearance for BiliWrap, the first portable and disposable phototherapy system designed for neonates. The system provides an effective treatment solution for unconjugated hyperbilirubinemia, offering clinicians a flexible, single-use alternative to traditional, non-portable phototherapy units in both clinical and neonatal care settings. |
| Phothera | Jan-25 | Daavlin and National Biological (NatBio) merged to form a new entity, Phothera. This strategic consolidation of two industry leaders combines their expertise in UV light phototherapy, creating a unified platform for home and clinical devices and strengthening the company's position in the global phototherapy equipment market. |
| Xuzhou Kernel Medical | Feb-25 | Xuzhou Kernel Medical received FDA clearance for its 308nm Excimer Phototherapy Device. This targeted light therapy system is indicated for the treatment of dermatological conditions including psoriasis and vitiligo, providing practitioners with a precision-based device to deliver therapeutic UV light directly to affected skin areas. |
| Twellium Industrial Company Limited | May-24 | Twellium Industrial Company Limited donated phototherapy units and neonatal incubators to select healthcare facilities in Ghana via its "Verna Changing Lives" initiative. This corporate social responsibility effort significantly strengthens local neonatal intensive care capacity, improving patient access to critical phototherapy treatment for jaundice in underserved regions. |
| Daavlin | Dec-23 | Daavlin received FDA clearance for its DT Controlled Phototherapy Equipment. The system is specifically indicated for the treatment of diagnosed skin disorders, offering advanced dosage control and safety features that enable healthcare providers to standardize therapeutic delivery for patients undergoing light therapy for chronic conditions. |
| NeoLight LLC | Nov-21 | NeoLight LLC completed the acquisition of Phoenix Technology Group LLC, a company with a global distribution network spanning over 95 countries. This acquisition provides NeoLight with an established international infrastructure, enabling the rapid geographic expansion and commercialization of its neonatal phototherapy devices to new markets worldwide. |
Frequently Asked Questions
How much is the phototherapy equipment market worth?
The market size of phototherapy equipment in 2026 is calculated to be USD 441.41 million.
What is the expected industry size of phototherapy equipment by 2035?
Phototherapy Equipment Market size is estimated to increase from USD 426.07 million in 2025 to USD 642.92 million by 2035 supported by a CAGR exceeding 4.2% during 2026-2035.
How is neonatal jaundice treatment influencing hospital and home-based adoption in the phototherapy equipment market?
Rising neonatal jaundice cases are driving hospitals to expand phototherapy units for rapid bilirubin control, while also increasing adoption of compact home-based systems that enable earlier discharge and reduce inpatient care pressure.
How are dermatology treatment trends and portable technologies reshaping utilization of phototherapy equipment?
Growing psoriasis and eczema cases are increasing repeat phototherapy sessions in clinics, while portable LED devices are expanding access in rural settings by reducing infrastructure needs and improving treatment availability outside advanced hospitals.
Why do Hospitals & Clinics lead the phototherapy equipment market?
Hospitals & Clinics accounted for 78.66% of the market in 2025, supported by trained staff, continuous patient monitoring, physician supervision, and access to a broad range of phototherapy equipment.
What is fueling growth in Neonatal Jaundice Management within the phototherapy equipment market?
Neonatal Jaundice Management is the fastest-growing application because phototherapy remains a frontline treatment for newborn care, creating consistent demand for timely and effective bilirubin management.
What factors support North America's leadership in the phototherapy equipment market?
North America held a 41.34% market share in 2025, driven by established hospital and neonatal care infrastructure, routine equipment replacement, specialized care access, and strong integration of phototherapy systems into clinical workflows.
Why is Asia Pacific emerging as the fastest-growing phototherapy equipment market?
Asia Pacific is expected to expand at a 4.79% CAGR as healthcare capacity grows, maternal and neonatal services expand, and hospitals increase adoption of phototherapy equipment to serve rising patient volumes.
What are the key competitors in the phototherapy equipment landscape?
Key companies in the phototherapy equipment market include Koninklijke Philips N.V. (Netherlands), GE HealthCare Technologies Inc. (United States), Natus Medical Incorporated (United States), Herbert Waldmann GmbH & Co. KG (Germany), Atom Medical Corporation (Japan), Nice Neotech Medical Systems Pvt. Ltd. (India), Phoenix Medical Systems Pvt. Ltd. (India), National Biological Corporation (United States), Solarc Systems Inc. (Canada), Drägerwerk AG & Co. KGaA (Germany).
Our Clients
Why Choose Us
Specialized Expertise: Our team comprises industry experts with a deep understanding of your market segment. We bring specialized knowledge and experience that ensures our research and consulting services are tailored to your unique needs.
Customized Solutions: We understand that every client is different. That's why we offer customized research and consulting solutions designed specifically to address your challenges and capitalize on opportunities within your industry.
Proven Results: With a track record of successful projects and satisfied clients, we have demonstrated our ability to deliver tangible results. Our case studies and testimonials speak to our effectiveness in helping clients achieve their goals.
Cutting-Edge Methodologies: We leverage the latest methodologies and technologies to gather insights and drive informed decision-making. Our innovative approach ensures that you stay ahead of the curve and gain a competitive edge in your market.
Client-Centric Approach: Your satisfaction is our top priority. We prioritize open communication, responsiveness, and transparency to ensure that we not only meet but exceed your expectations at every stage of the engagement.
Continuous Innovation: We are committed to continuous improvement and staying at the forefront of our industry. Through ongoing learning, professional development, and investment in new technologies, we ensure that our services are always evolving to meet your evolving needs.
Value for Money: Our competitive pricing and flexible engagement models ensure that you get maximum value for your investment. We are committed to delivering high-quality results that help you achieve a strong return on your investment.
Select Licence Type
